These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 6800052)

  • 1. Transitoriness of the alteration of factor VIII in von Willebrand's disease.
    Castillo R; Maragall S; Monteagudo J; Ordinas A
    Thromb Haemost; 1981 Dec; 46(4):760. PubMed ID: 6800052
    [No Abstract]   [Full Text] [Related]  

  • 2. Studies on the pathophysiology and treatment of von Willebrand's disease. II. Gel filtration studies on plasma factor VIII in von Willebrand's disease.
    Takahashi H
    Nihon Ketsueki Gakkai Zasshi; 1981 Feb; 44(1):165-72. PubMed ID: 6797214
    [No Abstract]   [Full Text] [Related]  

  • 3. Proceedings: Abnormal factor VIII in von Willebrand's disease.
    Thompson C; Forbes CD; Prentice CR
    Br J Haematol; 1974 Sep; 28(1):144. PubMed ID: 4547281
    [No Abstract]   [Full Text] [Related]  

  • 4. Von Willebrand's disease complicating second-trimester abortion.
    Sorosky J; Klatsky A; Nobert GF; Burchell RC
    Obstet Gynecol; 1980 Feb; 55(2):253-4. PubMed ID: 6965426
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Proceedings: An abnormality of factor-VIII-related protein (FVIIIRP)--possible variants of von Willebrand's disease.
    Peake IR; Giddings JC; Bloom AL
    Br J Haematol; 1974 Sep; 28(1):143-4. PubMed ID: 4547282
    [No Abstract]   [Full Text] [Related]  

  • 6. [von Willebrand's disease with an increased ristocetin-induced platelet aggregation and a qualitative abnormality of the factor VIII protein (author's transl)].
    Takahashi H; Oda E; Hattori A; Kobayashi I; Takahashi K; Sakuragawa N; Shibata A
    Rinsho Ketsueki; 1980 Apr; 21(4):544-54. PubMed ID: 6774131
    [No Abstract]   [Full Text] [Related]  

  • 7. Acquired von Willebrand's syndrome associated with decrease of plasminogen activator and its inhibitor during hypothyroidism.
    Levesque H; Borg JY; Cailleux N; Vasse M; Daliphard S; Gancel A; Monconduit M; Courtois H
    Eur J Med; 1993 May; 2(5):287-8. PubMed ID: 8252160
    [TBL] [Abstract][Full Text] [Related]  

  • 8. von Willebrand's Disease.
    Zimmerman TS; Ruggeri ZM
    Clin Haematol; 1983 Feb; 12(1):175-200. PubMed ID: 6404576
    [No Abstract]   [Full Text] [Related]  

  • 9. [Diagnosis of Von Willebrand's syndrome (author's transl)].
    Hariga-Muller C; Capel P; De Maertelaere-Laurent E; Masramon AM; Fondu P
    Rev Med Brux; 1981 Mar; 2(3):245-50. PubMed ID: 6785854
    [No Abstract]   [Full Text] [Related]  

  • 10. Heterogeneity in von Willebrand's disease.
    Ruggeri ZM; Zimmerman TS
    Prog Clin Biol Res; 1981; 72():139-48. PubMed ID: 6801683
    [No Abstract]   [Full Text] [Related]  

  • 11. Proceedings: Mechanisms of the prolonged bleeding time in von Willebrand's disease (vWd).
    Mannucci PM; Holmberg L; Ruggeri ZM; Nilsson IM
    Thromb Diath Haemorrh; 1975 Nov; 34(2):607. PubMed ID: 1081755
    [No Abstract]   [Full Text] [Related]  

  • 12. Studies on the pathophysiology and treatment of von Willebrand's disease. I. Spectrum of von Willebrand's disease in Niigata.
    Takahashi H
    Nihon Ketsueki Gakkai Zasshi; 1981 Feb; 44(1):154-64. PubMed ID: 6797213
    [No Abstract]   [Full Text] [Related]  

  • 13. Proceedings: Transfusion and gel filtration studies in von Willebrand's disease.
    Kernoff PB; Rizza CR; Kaelin AC
    Br J Haematol; 1974 Jun; 27(2):364. PubMed ID: 4546378
    [No Abstract]   [Full Text] [Related]  

  • 14. Application of immunological techniques to the study of classic haemophilia and von Willebrand's disease.
    Bennett B
    Br J Haematol; 1973 Aug; 25(2):273-4. PubMed ID: 4580214
    [No Abstract]   [Full Text] [Related]  

  • 15. [Application if different techniques to the diagnosis of von Willebrand's disease (author's transl)].
    Solana JM; Rocha E; Arrizabalaga B; López A; Febres R; Fernández J
    Sangre (Barc); 1981; 26(6):1156-63. PubMed ID: 6805084
    [No Abstract]   [Full Text] [Related]  

  • 16. [New information about von Willebrand's disease ilustrated by our cases (author's transl)].
    Oberiter V; Knezević J
    Lijec Vjesn; 1980 Feb; 102(2):89-92. PubMed ID: 6772899
    [No Abstract]   [Full Text] [Related]  

  • 17. [Von Willebrand disease--type 2N (case report)].
    Zarnovicanová M; Pelikánová S
    Vnitr Lek; 2003 Apr; 49(4):319-21. PubMed ID: 12793057
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Acquired Von Willebrand's disease. Apropos of 2 cases].
    Flechet B; Borg JY; Legendre M; Piguet H
    LARC Med; 1984 Jan; 4(1):15-21. PubMed ID: 6425585
    [No Abstract]   [Full Text] [Related]  

  • 19. Von Willebrand's disease: a clinical and molecular enigma. Twelfth Annual Paul M. Aggeler Memorial Lecture.
    Nachman RL
    West J Med; 1982 Apr; 136(4):318-25. PubMed ID: 6806985
    [No Abstract]   [Full Text] [Related]  

  • 20. [Clinical features of our patients with von Willebrand's disease (author's transl)].
    Takahashi H; Koike K; Itoh M; Hattori A; Kobayashi I; Takahashi K; Sakuragawa N; Shibata A; Matsuoka M; Tsukada T
    Rinsho Ketsueki; 1980 Feb; 21(2):179-88. PubMed ID: 6774127
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.